These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 538090)

  • 1. Monitoring plasma concentrations of psychotropic drugs as an aid to treatment.
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Nov; 12(6):445. PubMed ID: 538090
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug concentrations in neuropsychiatry.
    Biol Psychiatry; 1980 Feb; 15(1):177-9. PubMed ID: 7357056
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic drug monitoring (TDM) of psychotropic drugs: a consensus guideline of the AGNP-TDM group].
    Baumann P; Hiemke C; Ulrich S; Eckermann G; Kuss HL; Laux G; Müller-Oerlingenhausen B; Rao ML; Riederer P; Zernig G; ;
    Rev Med Suisse; 2006 May; 2(67):1413-8, 1420-2, 1424-6. PubMed ID: 16786958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of psychopharmaceuticals--should serum concentration be checked?].
    Andersen S; Refsum H; Tanum L
    Tidsskr Nor Laegeforen; 2004 Sep; 124(18):2362-4. PubMed ID: 15467801
    [No Abstract]   [Full Text] [Related]  

  • 5. A common single binding site for many psychotropic drugs on human alpha 1-acid glycoprotein. Therapeutically relevant observation?
    Müller WE
    Pharmacopsychiatry; 1985 Jul; 18(4):257-8. PubMed ID: 4023049
    [No Abstract]   [Full Text] [Related]  

  • 6. [Correlations between plasmatic concentrations and clinical effects of psychotropic drugs].
    Predescu V; Costa D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1979; 24(4):265-71. PubMed ID: 394259
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychotropic blood levels: a guide to clinical response.
    Yesavage JA
    J Clin Psychiatry; 1986 Sep; 47 Suppl():16-9. PubMed ID: 2875066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.
    Baumann P; Hiemke C; Ulrich S; Eckermann G; Gaertner I; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Rao ML; Riederer P; Zernig G;
    Pharmacopsychiatry; 2004 Nov; 37(6):243-65. PubMed ID: 15551191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complexity of active metabolites in therapeutic drug monitoring of psychotropic drugs.
    Hendset M; Haslemo T; Rudberg I; Refsum H; Molden E
    Pharmacopsychiatry; 2006 Jul; 39(4):121-7. PubMed ID: 16871467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug concentrations in neuropsychiatry.
    Ciba Found Symp; 1979; (74):1-266. PubMed ID: 261679
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacokinetics of psychotropic drugs: importance in psychiatric practice].
    Vandel B; Bonin B; Vandel S
    Sem Hop; 1982 Dec; 58(44):2597-2605. PubMed ID: 6297053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gender based psychopharmacology: gender influence in the pharmacological treatment of mental disorders].
    Usall i Rodié J
    Actas Esp Psiquiatr; 2004; 32(5):307-13. PubMed ID: 15529216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of some psychoactive drugs and relationships to clinical response.
    Gottschalk LA
    Methods Find Exp Clin Pharmacol; 1985 May; 7(5):275-82. PubMed ID: 3897748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychiatric drug treatment and drug plasma levels].
    Syvälahti E
    Duodecim; 1995; 111(8):675-6, 679-80. PubMed ID: 8681826
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioavailability of psychotropic drugs: historical perspective and pharmacokinetic overview.
    Ereshefsky L; Jann MW; Saklad SR; Davis CM
    J Clin Psychiatry; 1986 Sep; 47 Suppl():6-15. PubMed ID: 3528134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thin-layer chromatographic determination of plasma levels of tricyclic psychopharmacological drugs: first results on their relationship to the clinical activity of neuroleptics (author's transl)].
    Breyer U; Petruch F; Gaertner HJ; Pflug B
    Arzneimittelforschung; 1976; 26(6):1153. PubMed ID: 989405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of psychotropics in patients with kidney failure.
    Levy NB
    Psychosomatics; 1985 Sep; 26(9):699-701, 705, 709. PubMed ID: 4048374
    [No Abstract]   [Full Text] [Related]  

  • 18. Haematological toxicity of drugs used in psychiatry.
    Flanagan RJ; Dunk L
    Hum Psychopharmacol; 2008 Jan; 23 Suppl 1():27-41. PubMed ID: 18098216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rules for prescribing psychotropic drugs. Importance of symptomatic and pharmacologic data].
    Loloum T
    Soins Psychiatr; 1983 Nov; (37):16-8. PubMed ID: 6560814
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyponatremia due to psychotropic drugs.
    Sandifer MG
    J Clin Psychiatry; 1983 Aug; 44(8):301-3. PubMed ID: 6409891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.